FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2111892488> ?p ?o ?g. }

• W2111892488 endingPage "748" @default.
• W2111892488 startingPage "738" @default.
• W2111892488 abstract "Rituximab effectively reduces proteinuria in patients with idiopathic membranous nephropathy (IMN), but response to treatment may vary from patient to patient. The association between baseline clinical, laboratory, and histology covariates and proteinuria reduction was evaluated retrospectively by multiple linear regression analysis at 3 mo after rituximab therapy in 14 patients with IMN with proteinuria >3.5 g/24 h while on angiotensin-converting enzyme inhibition for at least 6 mo and no previous remissions. The association strength was expressed by standardized β coefficients (SβC). Glomerular (SβC = 0.48, <i>P</i> = 0.049) and tubulointerstitial (TI) scores (SβC = 0.61, <i>P</i> = 0.003) predicted the outcome. Among glomerular and TI score components, tubular atrophy (SβC = 0.59, <i>P</i> = 0.003) and interstitial fibrosis (SβC = 0.60, <i>P</i> = 0.001) were significantly associated with 3-mo proteinuria. Urinary protein excretion decreased from 9.1 ± 4.0 to 4.6 ± 3.5 g/24 h (<i>P</i> < 0.001) in eight patients with TI score <1.7 but did not change in six with a score ≥1.7. Nine additional patients with IMN then were allocated prospectively to rituximab treatment on the basis of a TI score <1.7. Three-month proteinuria decreased in all patients from 8.9 ± 5.3 to 4.9 ± 3.9 g/24 h (<i>P</i> < 0.001) and serum albumin increased from 2.2 ± 0.6 to 2.8 ± 0.5 mg/dl (<i>P</i> < 0.01). Changes in serum albumin and cholesterol were inversely correlated (<i>P</i> < 0.02, <i>r</i> = −0.44). Rituximab achieved CD₂₀ and CD₁₉ depletion in all patients. In patients with IMN and nephrotic proteinuria despite angiotensin-converting enzyme inhibition therapy, renal biopsy findings may help in predicting response to rituximab and defining selection criteria for randomized trials that aim to assess the risk/benefit profile of B cell target therapy as compared with aspecific immunosuppressants and/or conservative therapy alone." @default.
• W2111892488 created "2016-06-24" @default.
• W2111892488 creator A5004877633 @default.
• W2111892488 creator A5005075162 @default.
• W2111892488 creator A5011057274 @default.
• W2111892488 creator A5023556434 @default.
• W2111892488 creator A5052434587 @default.
• W2111892488 creator A5059276594 @default.
• W2111892488 creator A5078814791 @default.
• W2111892488 date "2006-07-01" @default.
• W2111892488 modified "2023-10-14" @default.
• W2111892488 title "Rituximab for Idiopathic Membranous Nephropathy" @default.
• W2111892488 cites W1977303408 @default.
• W2111892488 cites W1988067223 @default.
• W2111892488 cites W1988853553 @default.
• W2111892488 cites W1995791071 @default.
• W2111892488 cites W2006666860 @default.
• W2111892488 cites W2018680608 @default.
• W2111892488 cites W2026639881 @default.
• W2111892488 cites W2034759249 @default.
• W2111892488 cites W2050580993 @default.
• W2111892488 cites W2051702141 @default.
• W2111892488 cites W2084144472 @default.
• W2111892488 cites W2096397040 @default.
• W2111892488 cites W2107002794 @default.
• W2111892488 cites W2118994799 @default.
• W2111892488 cites W2119682331 @default.
• W2111892488 cites W2139335975 @default.
• W2111892488 cites W2139643740 @default.
• W2111892488 cites W2141219630 @default.
• W2111892488 cites W2168495534 @default.
• W2111892488 cites W4242848679 @default.
• W2111892488 cites W2021969847 @default.
• W2111892488 doi "https://doi.org/10.2215/cjn.01080905" @default.
• W2111892488 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17699281" @default.
• W2111892488 hasPublicationYear "2006" @default.
• W2111892488 type Work @default.
• W2111892488 sameAs 2111892488 @default.
• W2111892488 citedByCount "88" @default.
• W2111892488 countsByYear W21118924882012 @default.
• W2111892488 countsByYear W21118924882013 @default.
• W2111892488 countsByYear W21118924882014 @default.
• W2111892488 countsByYear W21118924882015 @default.
• W2111892488 countsByYear W21118924882016 @default.
• W2111892488 countsByYear W21118924882017 @default.
• W2111892488 countsByYear W21118924882018 @default.
• W2111892488 countsByYear W21118924882019 @default.
• W2111892488 countsByYear W21118924882020 @default.
• W2111892488 countsByYear W21118924882021 @default.
• W2111892488 countsByYear W21118924882022 @default.
• W2111892488 countsByYear W21118924882023 @default.
• W2111892488 crossrefType "journal-article" @default.
• W2111892488 hasAuthorship W2111892488A5004877633 @default.
• W2111892488 hasAuthorship W2111892488A5005075162 @default.
• W2111892488 hasAuthorship W2111892488A5011057274 @default.
• W2111892488 hasAuthorship W2111892488A5023556434 @default.
• W2111892488 hasAuthorship W2111892488A5052434587 @default.
• W2111892488 hasAuthorship W2111892488A5059276594 @default.
• W2111892488 hasAuthorship W2111892488A5078814791 @default.
• W2111892488 hasBestOaLocation W21118924881 @default.
• W2111892488 hasConcept C126322002 @default.
• W2111892488 hasConcept C126894567 @default.
• W2111892488 hasConcept C134018914 @default.
• W2111892488 hasConcept C2775946357 @default.
• W2111892488 hasConcept C2779338263 @default.
• W2111892488 hasConcept C2779561371 @default.
• W2111892488 hasConcept C2780091579 @default.
• W2111892488 hasConcept C2780653079 @default.
• W2111892488 hasConcept C2781184683 @default.
• W2111892488 hasConcept C555293320 @default.
• W2111892488 hasConcept C71924100 @default.
• W2111892488 hasConcept C90924648 @default.
• W2111892488 hasConceptScore W2111892488C126322002 @default.
• W2111892488 hasConceptScore W2111892488C126894567 @default.
• W2111892488 hasConceptScore W2111892488C134018914 @default.
• W2111892488 hasConceptScore W2111892488C2775946357 @default.
• W2111892488 hasConceptScore W2111892488C2779338263 @default.
• W2111892488 hasConceptScore W2111892488C2779561371 @default.
• W2111892488 hasConceptScore W2111892488C2780091579 @default.
• W2111892488 hasConceptScore W2111892488C2780653079 @default.
• W2111892488 hasConceptScore W2111892488C2781184683 @default.
• W2111892488 hasConceptScore W2111892488C555293320 @default.
• W2111892488 hasConceptScore W2111892488C71924100 @default.
• W2111892488 hasConceptScore W2111892488C90924648 @default.
• W2111892488 hasIssue "4" @default.
• W2111892488 hasLocation W21118924881 @default.
• W2111892488 hasLocation W21118924882 @default.
• W2111892488 hasLocation W21118924883 @default.
• W2111892488 hasOpenAccess W2111892488 @default.
• W2111892488 hasPrimaryLocation W21118924881 @default.
• W2111892488 hasRelatedWork W1583849384 @default.
• W2111892488 hasRelatedWork W1985654865 @default.
• W2111892488 hasRelatedWork W2018459774 @default.
• W2111892488 hasRelatedWork W2281776699 @default.
• W2111892488 hasRelatedWork W2390690038 @default.
• W2111892488 hasRelatedWork W2560171887 @default.
• W2111892488 hasRelatedWork W2728745795 @default.
• W2111892488 hasRelatedWork W2793261888 @default.

• next